Abstract

Objective: To evaluate the association of the degree of gingival inflammation and 25-hydroxy Vitamin D (25(OH)D) level in postmenopausal women.Methods: A cross-sectional study involved 71 postmenopausal women. Data were obtained using questionnaires, clinical periodontal examinations, and evaluations of blood samples. Serum 25(OH)D concentrations were determined using human 25-dihydroxy Vitamin D ELISA kit.Result: Prevalence of Vitamin D deficiency among postmenopausal women was 74.64%. The papillary bleeding index (PBI) was lower (1.07±0.18) in postmenopausal women with normal serum 25(OH)D levels than that in postmenopausal women with Vitamin D deficiency (1.41±0.1). However, this difference was not statistically significant (p<0.05). This result indicated increasing trends in PBI.Conclusion: There is no association between the degree of gingival inflammation and the 25(OH)D status among postmenopausal women.

Highlights

  • Menopause is defined as the cessation of menstruation for at least 1 year due to estrogen deficiency

  • There is no association between the degree of gingival inflammation and the 25(OH)D status among postmenopausal women

  • This study showed that the women with normal 25(OH)D levels (16.06 ± 3.95 min/week) tended to have longer sun exposure than those with Vitamin D deficiency (15.33 ± 2.97 min/week); this difference was not statistically significant (Table 3)

Read more

Summary

Introduction

Menopause is defined as the cessation of menstruation for at least 1 year due to estrogen deficiency. A considerable proportion of the population is affected by estrogen deficiency; there are approximately 70 million women in the United States >50 years of age [1]. It is estimated that there will be 60 million menopausal women in Indonesia by 2025. In Indonesia, there are 14 million menopausal women, comprising 7.4% of the total population [2]. Multiple health issues affect postmenopausal women and compromise their quality of life. Postmenopausal women may experience several symptoms [3], including cardiovascular disease, osteoporosis, cancer, cognitive decline and dementia, chronic obstructive pulmonary disease, diabetes mellitus, metabolic syndrome, depression, vasomotor symptoms, sleep disturbances, and migraine [3,4]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.